跳转至内容
Merck
CN

HPLC Analysis of Lidocaine and Related Compound A and H on Purospher®STAR RP-18 endcapped

HPLC Analysis of Lidocaine and Related Compound A and H on Purospher®STAR RP-18 endcapped application for HPLC

材料

used together

产品编号
说明
价格

Phosphoric acid

≥85 wt. % in H2O, ≥99.999% trace metals basis

相关产品

产品编号
说明
价格

Lidocaine

powder

Lidocaine Related Compound A

Pharmaceutical Secondary Standard; Certified Reference Material

Lidocaine Related Compound H

Pharmaceutical Secondary Standard; Certified Reference Material

CONDITIONS

column

Purostar RP18E 2MYM HI-HR100-2.1 mm (1.50648.0001)

mobile phase

[A] 95/5 water / acetonitrile in 0.1% phosphoric acid; [B] 5/95 water/acetonitrile in 0.1% phosphoric acid

gradient

0% B for 2 min, then 0% to 100% B in 10 min; 100% to 0% B in 0.1 min; hold at 0% B for 4.9 min.

flow rate

0.3 mL/min

pressure

4656 psi (321 bar)

column temp.

30 °C

detector

210 nm UV

injection

1 μL

sample

100 μg/mL of lidocaine, related compound A and H in acetonitrile

说明

分析说明

Lidocaine is a medication used to numb tissue in a specific area and does not affect other areas. Topically it can be used for reducing pain by irritations such as sunburn, poison ivy, insect bites, minor cuts or even hemorrhoids. It can also be used for local anesthetic with sedative, analgesic and cardiac depressant (antiarrhythmic drug) properties This application demonstrates reverse phase interactions in a simple gradient separating lidocaine and two of its related compounds using Cerilliant CRM′s for the related compounds.

法律信息

Purospher is a registered trademark of Merck KGaA, Darmstadt, Germany